Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis
Science Advances · 2025
DOI: 10.1126/sciadv.ads3829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Liang He und 18 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Tongji University School of Medicine, Shanghai, PR. China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Osteogenesis, Osteoclasts, Osteoporosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Adhesion G protein–coupled receptors (GPCRs) play crucial roles in numerous physiological and pathological conditions. However, the functions of adhesion GPCRs remain poorly understood because of the lack of effective modulators. Here, we used the adhesion GPCR D1 (ADGRD1/GPR133) as a model to unveil a strategy for finding exogenous agonists that target adhesion GPCRs while revealing previously unidentified functions of ADGRD1. We identified the small molecule GL64 as a selective agonist of ADGRD1. GL64 activates ADGRD1 by mimicking the stachel sequence. Using GL64 as a chemical tool, we demonstrated that ADGRD1 negatively regulates bone loss by inhibiting osteoclastogenesis. The cAMP-PKA-NFATC1 pathway was identified as the downstream signaling pathway of ADGRD1 in osteoclasts. Furthermore, administering GL64 prevented bone loss and suppressed osteoclast activity in the osteoporosis mouse model induced by ovariectomy. Our findings provide mechanistic insights into the activation of adhesion GPCRs by exogenous agonists and underscore the therapeutic potential of targeting ADGRD1 in osteoclast-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Tongji University School of Medicine, Shanghai, PR. China.
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, PR. China.
- Key Laboratory of Adolescent Health Assessment and Exercise Intervention of the Ministry of Education, East China Normal University, Shanghai, P. R. China.
- Central Laboratory, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, P. R. China.
- Advanced Medical Research Institute, Cheeloo College of Medicine, NHC Key Laboratory of Otorhinolaryngology, the Laboratory of New Cornerstone Investigator, Shandong University, Jinan, China.
- Department of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan, China.
ORCID-Profile: Liang He, Qiansen Zhang, Yu You, Peng Sun, Shaoying Zhang, Lei Zhao, Mingyao Liu, Jin-Peng Sun, Ning Wang, Yeqing Sun, Huaiyu Yang, Jian Luo
Zitieren
APA
He, L., Zhang, Q., You, Y., Sun, P., Xu, Z., Li, R., Wang, F., Zhang, S., He, J., Shen, J., Zhao, L., Hong, Y., Li, Y., Liu, M., Sun, J. P., Wang, N., Sun, Y., Yang, H., & Luo, J. (2025). Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis. Science Advances. https://doi.org/10.1126/sciadv.ads3829
Vancouver
He L, Zhang Q, You Y, Sun P, Xu Z, Li R, et al. Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis. Science Advances. 2025. doi:10.1126/sciadv.ads3829
BibTeX
@article{He2025,
author = {He, Liang and Zhang, Qiansen and You, Yu and Sun, Peng and Xu, Ziwei and Li, Rong and Wang, Fanhua and Zhang, Shaoying and He, Jiangnan and Shen, Juwen and Zhao, Lei and Hong, Yang and Li, Yinghua and Liu, Mingyao and Sun, Jin-Peng and Wang, Ning and Sun, Yeqing and Yang, Huaiyu and Luo, Jian},
title = {Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.ads3829}
}
EUVIMED